Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Dr. Thomas Grader-Beck, M.D

Rheumatology Baltimore, MD Male

NPI: 1336163500

Total Payments

$100,607

2024 Payments

$2,991

Companies

Transactions

Medicare Patients

770

Medicare Billing

$89,637

Payment Breakdown by Category

Research$68,383 (68.0%)

Consulting$29,073 (28.9%)

Travel$2,173 (2.2%)

Food & Beverage$977.13 (1.0%)

Education$1.00 (0.0%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Unspecified	$68,383	3	68.0%
Consulting Fee	$29,073	7	28.9%
Travel and Lodging	$2,173	8	2.2%
Food and Beverage	$977.13	10	1.0%
Education	$1.00	1	0.0%

Payments by Type

Research

$68,383

3 transactions

General

$32,224

26 transactions

Top Paying Companies

Company	Total	Records	Latest Year
Eli Lilly and Company	$67,233	3	$0 (2019)
Novartis Pharmaceuticals Corporation	$25,444	18	$0 (2024)
Novartis Pharma AG	$5,750	1	$0 (2023)
ARGENX US, INC.	$1,900	1	$0 (2023)
ABBVIE INC.	$267.78	4	$0 (2024)
Hologic, LLC	$11.26	1	$0 (2021)

Payment History by Year

Year	Amount	Transactions	Top Company
2024	$2,991	3	Novartis Pharmaceuticals Corporation ($2,875)
2023	$14,619	9	NOVARTIS PHARMACEUTICALS CORPORATION ($6,969)
2022	$7,869	4	Novartis Pharmaceuticals Corporation ($7,869)
2021	$2,031	2	Novartis Pharmaceuticals Corporation ($2,020)
2019	$67,234	4	Eli Lilly and Company ($67,233)
2018	$5,863	7	Novartis Pharmaceuticals Corporation ($5,711)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date	Company	Product	Nature	Form	Amount	Type
12/09/2024	Novartis Pharmaceuticals Corporation	—	Consulting Fee	Cash or cash equivalent	$2,875.00	General
11/19/2024	ABBVIE INC.	—	Food and Beverage	In-kind items and services	$84.50	General
11/19/2024	ABBVIE INC.	—	Food and Beverage	In-kind items and services	$31.20	General
12/19/2023	Novartis Pharma AG	COSENTYX (Biological)	—	Cash or cash equivalent	$5,750.00	Research
Study: Rheumatology Pipeline Studies • Category: IMMUNOLOGY
12/02/2023	NOVARTIS PHARMACEUTICALS CORPORATION	—	Consulting Fee	Cash or cash equivalent	$5,737.50	General
12/02/2023	NOVARTIS PHARMACEUTICALS CORPORATION	—	Travel and Lodging	In-kind items and services	$313.10	General
12/02/2023	NOVARTIS PHARMACEUTICALS CORPORATION	—	Travel and Lodging	In-kind items and services	$292.67	General
12/02/2023	NOVARTIS PHARMACEUTICALS CORPORATION	—	Food and Beverage	In-kind items and services	$174.59	General
12/02/2023	NOVARTIS PHARMACEUTICALS CORPORATION	—	Travel and Lodging	Cash or cash equivalent	$116.25	General
12/01/2023	NOVARTIS PHARMACEUTICALS CORPORATION	—	Travel and Lodging	In-kind items and services	$194.48	General
12/01/2023	NOVARTIS PHARMACEUTICALS CORPORATION	—	Food and Beverage	In-kind items and services	$139.99	General
05/03/2023	ARGENX US, INC.	VYVGART (Drug)	Consulting Fee	Cash or cash equivalent	$1,900.00	General
Category: Immunology
11/04/2022	Novartis Pharmaceuticals Corporation	—	Travel and Lodging	In-kind items and services	$224.87	General
11/04/2022	Novartis Pharmaceuticals Corporation	—	Food and Beverage	In-kind items and services	$162.12	General
11/03/2022	Novartis Pharmaceuticals Corporation	—	Travel and Lodging	In-kind items and services	$581.99	General
03/14/2022	Novartis Pharmaceuticals Corporation	—	Consulting Fee	Cash or cash equivalent	$6,900.00	General
09/29/2021	Novartis Pharmaceuticals Corporation	—	Consulting Fee	Cash or cash equivalent	$2,020.00	General
09/28/2021	Hologic, LLC	MYOSURE TISSUE REMOVAL DEVICE (Device)	Food and Beverage	In-kind items and services	$11.26	General
Category: Surgical
12/04/2019	Eli Lilly and Company	—	Consulting Fee	Cash or cash equivalent	$4,600.00	General
07/18/2019	Lilly USA, LLC	—	Education	In-kind items and services	$1.00	General
03/22/2019	Eli Lilly and Company	—	—	In-kind items and services	$1,786.00	Research
Study: A MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS AND PHARMACODYNAMICS OF LY3090106 IN SUBJECTS WITH SJOGRENS SYNDROME
01/07/2019	Eli Lilly and Company	—	—	Cash or cash equivalent	$60,847.00	Research
Study: A MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS AND PHARMACODYNAMICS OF LY3090106 IN SUBJECTS WITH SJOGRENS SYNDROME
11/30/2018	Novartis Pharmaceuticals Corporation	—	Consulting Fee	Cash or cash equivalent	$5,040.00	General
11/30/2018	Novartis Pharmaceuticals Corporation	—	Travel and Lodging	Cash or cash equivalent	$250.28	General
11/30/2018	Novartis Pharmaceuticals Corporation	—	Travel and Lodging	In-kind items and services	$199.45	General

1 2 »

Research Studies & Clinical Trials

Study Name	Company	Amount	Records
A MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS AND PHARMACODYNAMICS OF LY3090106 IN SUBJECTS WITH SJOGRENS SYNDROME	Eli Lilly and Company	$62,633	2
Rheumatology Pipeline Studies	Novartis Pharma AG	$5,750	1

Medicare Billing by Year

Year	Procedures	Beneficiaries	Services	Submitted	Medicare Paid
2023	2	201	247	$69,665	$22,771
2022	4	224	269	$81,340	$26,754
2021	4	199	232	$74,816	$26,242
2020	2	146	177	$49,752	$13,869

Total Patients

770

Total Services

925

Medicare Billing

$89,637

Procedure Codes

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS	Description	Setting	Year	Patients	Services	Charges	Medicare Paid	Ratio
99214	Established patient office or other outpatient visit, 30-39 minutes	Office	2023	114	144	$43,760	$14,176	32.4%
99214	Established patient office or other outpatient visit, 30-39 minutes	Facility	2023	74	90	$19,736	$6,696	33.9%
99205	New patient office or other outpatient visit, 60-74 minutes	Facility	2023	13	13	$6,169	$1,898	30.8%
99214	Established patient office or other outpatient visit, 30-39 minutes	Office	2022	132	160	$45,766	$15,023	32.8%
99214	Established patient office or other outpatient visit, 30-39 minutes	Facility	2022	46	62	$13,020	$4,315	33.1%
99205	New patient office or other outpatient visit, 60-74 minutes	Office	2022	22	22	$12,232	$4,110	33.6%
99204	New patient office or other outpatient visit, 45-59 minutes	Office	2022	13	13	$5,746	$1,743	30.3%
99215	Established patient office or other outpatient visit, 40-54 minutes	Office	2022	11	12	$4,576	$1,563	34.2%
99214	Established patient outpatient visit, total time 30-39 minutes	Office	2021	89	115	$32,840	$11,611	35.4%
99205	New patient outpatient visit, total time 60-74 minutes	Office	2021	20	20	$11,120	$3,825	34.4%
99214	Established patient outpatient visit, total time 30-39 minutes	Facility	2021	32	36	$7,560	$3,004	39.7%
99215	Established patient outpatient visit, total time 40-54 minutes	Office	2021	19	19	$6,931	$2,207	31.8%
99204	New patient outpatient visit, total time 45-59 minutes	Office	2021	15	15	$6,630	$2,068	31.2%
99205	New patient outpatient visit, total time 60-74 minutes	Facility	2021	11	11	$4,983	$1,775	35.6%
99215	Established patient outpatient visit, total time 40-54 minutes	Facility	2021	13	16	$4,752	$1,752	36.9%
99214	Established patient office or other outpatient, visit typically 25 minutes	Office	2020	111	139	$38,275	$10,519	27.5%
99205	New patient office or other outpatient visit, typically 60 minutes	Office	2020	11	11	$5,807	$1,807	31.1%
99214	Established patient office or other outpatient, visit typically 25 minutes	Facility	2020	24	27	$5,670	$1,543	27.2%

About Dr. Thomas Grader-Beck, M.D

Dr. Thomas Grader-Beck, M.D is a Rheumatology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336163500.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Grader-Beck, M.D has received a total of $100,607 in payments from pharmaceutical and medical device companies, with $2,991 received in 2024. These payments were reported across 29 transactions from 7 companies. The most common payment nature is "" ($68,383).

As a Medicare-enrolled provider, Grader-Beck has provided services to 770 Medicare beneficiaries, totaling 925 services with total Medicare billing of $89,637. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Rheumatology
Location Baltimore, MD
Active Since 07/27/2006
Last Updated 02/07/2013
Taxonomy Code 207RR0500X
Entity Type Individual
NPI Number 1336163500

Products in Payments

COSENTYX (Biological) $5,750
VYVGART (Drug) $1,900
MYOSURE TISSUE REMOVAL DEVICE (Device) $11.26

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.